Scarica l'app Stockscreener
1.13
0.00%
0.00
Precedente Chiudi:
$1.13
Aprire:
$1.12
Volume 24 ore:
42,917
Relative Volume:
0.54
Capitalizzazione di mercato:
$21.77M
Reddito:
-
Utile/perdita netta:
$-8.83M
Rapporto P/E:
-1.5454
EPS:
-0.7312
Flusso di cassa netto:
$-8.01M
1 W Prestazione:
+2.73%
1M Prestazione:
+15.28%
6M Prestazione:
+9.71%
1 anno Prestazione:
-22.65%
Intervallo 1D:
$1.10
$1.14
Intervallo di 1 settimana:
$1.10
$1.17
Portata 52W:
$0.76
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Nome
Cocrystal Pharma Inc
Settore
Industria
Telefono
(786) 459-1831
Indirizzo
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.13 | 22.54M | 0 | -8.83M | -8.01M | -0.7312 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-07-08 | Iniziato | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Borsa (COCP) Ultime notizie
Cocrystal (COCP) director Brosgart files with zero reported holdings - Stock Titan
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Cocrystal (COCP) Q1 2026 Results: The EPS Result Is Below Expectation in the Reported Period; After Earnings: The Share Price Adds 0.87%Dividend Increase Stocks - vinanet.vn
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma Adds Veteran Leader to Board of Directors - TipRanks
Cocrystal Pharma (NASDAQ: COCP) names Carol L. Brosgart to its board - Stock Titan
Cocrystal Pharma strengthens board with antiviral expert appointment - TipRanks
Cocrystal Pharma appoints Carol Brosgart to board to bolster antiviral development - TradingView
Cocrystal Pharma (COCP) appoints antiviral veteran to board - Stock Titan
Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol Brosgart to board of directors - Investing.com
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan
Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade
Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cocrystal Pharma (COCP) flags going-concern risk amid Q2 2026 loss and $5M raise - Stock Titan
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 million - Bitget
Cocrystal Pharma’s single oral drug for multiple viruses - drugdiscoverytrends.com
Cocrystal Pharma Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Cocrystal Pharma Inc (COCP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cocrystal Pharma (COCP) adds OPKO and insiders as major holders - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock By Investing.com - Investing.com South Africa
Phillip Frost details 13.9% Cocrystal Pharma (COCP) stake in update - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock - Investing.com
Cocrystal Pharma (COCP) insider buys 10,000 shares via trust - Stock Titan
Cocrystal Pharma, Inc. (COCP) insider-linked trust purchases 75,000 shares - Stock Titan
OPKO Health invests $5 million in Cocrystal Pharma By Investing.com - Investing.com
OPKO Health Boosts Stake in Cocrystal Pharma Financing - TipRanks
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - Stock Titan
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - globenewswire.com
OPKO Buys 5.47M Cocrystal Shares Ahead of Late-2026 Norovirus Data - Stock Titan
Cocrystal Pharma, Inc. Revenue Breakdown – NASDAQ:COCP - TradingView
Cocrystal Pharma Inc (COCP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cocrystal Pharma, Inc. announced that it has received $5 million in funding from OPKO Health, Inc. - marketscreener.com
Cocrystal Pharma (COCP) Edges Higher Near Support ZoneCombination Correction - dars.gov.et
Cocrystal Pharma Inc (COCP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cocrystal Pharma Inc (COCP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.919|Chg%:+0.019 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – FWB:8CC - TradingView
Cocrystal Pharma Inc (COCP) Institutional Confidence - TradingKey
Cocrystal Pharma Inc (COCP) Cash Flow - TradingKey
Cocrystal Pharma Inc (COCP) Income Statement - TradingKey
COCP|Cocrystal Pharma Inc|Price:1.110|Chg%:+0.030 - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.900|Chg%:-0.020 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – LS:A3DWYX - TradingView
What's Driving the Micro-Cap Mania in SKYQ and COCP - Kavout | AI
Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cocrystal Pharma Inc Azioni (COCP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Aug 03 '26 |
Buy |
0.94 |
75,000 |
70,590 |
1,983,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 24 '26 |
Buy |
1.00 |
20,000 |
19,952 |
1,908,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):